Atlas Trials

A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

Clinical trial NCT05067933 · TERMINATED

Trial details

NCT number
NCT05067933
Sponsor
Vaxart
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-10-22
Primary completion
2022-06-10
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.